|
|
|
Sunday, March 21, 2010 — 8:30 AM, Salon 1 and Balconies
|
- New Developments in Liver Pathology: A Clinicopathologic Update
|
|
Moderator:
|
M. Kay Washington, Vanderbilt University Medical Center, Nashville, TN
|
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. The speakers listed below have indicated they have nothing to disclose.
|
Click the button above to add this event to your Itinerary Planner...
| 8:30 | Beyond NASH: Update on Liver Pathology of Diabetes Mellitus and Fatty Liver Disease - David Kleiner, Laboratory of Pathology/National Cancer Institute, Bethesda, MD |
| 9:15 | Autoimmune Liver Disease: Update for Pathologists from the Hepatologist's Perspective - Jenny Heathcote, University of Toronto, Toronto, Canada |
| 10:00 | Break |
| 10:30 | Update on Iron Storage Disorders - Michael Torbenson, The Johns Hopkins University School of Medicine, Baltimore, MD |
| 11:15 | Update on New Diagnostic Methods for Well-Differentiated Hepatocellular Tumors - Sanjay Kakar, University of California, San Francisco and Veterans Affairs Medical Center, San Francisco, San Francisco, CA |
|
The members of the Executive Board selected topics based on presumed need as determined by the expertise of the committee members and input from the membership of the society at the annual business meeting. All concurred that specific problem areas of liver pathology addressed by speakers known to be highly knowledgeable in each area would be sought. The objectives are to educate the attendees regarding diagnostic problems and new diagnostic techniques in well-differentiated hepatocellular tumors, new developments in the clinical and pathologic features of autoimmune liver disease, iron storage disorders, diabetes mellitus and fatty liver disease.
|
|
|
|
